skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 237  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Female remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Material Type:
Article 		Add to My Research

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

Gut, 2015-11, Vol.64 (11), p.1744-1754 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307913 ;PMID: 25500202 ;CODEN: GUTTAK

Full text available

Citations Cited by
2
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Material Type:
Article 		Add to My Research

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945

Full text available

Citations Cited by
3
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Material Type:
Article 		Add to My Research

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609

Full text available

Citations Cited by
4
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

Citations Cited by
5
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Material Type:
Article 		Add to My Research

Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation

Diabetes (New York, N.Y.), 2016-08, Vol.65 (8), p.2282-2294 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 1, 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db16-0153 ;PMID: 27207552 ;CODEN: DIAEAZ

Full text available

Citations Cited by
6
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Material Type:
Article 		Add to My Research

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

The American journal of clinical nutrition, 2020-08, Vol.112 (2), p.413-426 [Peer Reviewed Journal]

2020 American Society for Nutrition. ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. 2020 ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. ;Copyright American Society for Clinical Nutrition, Inc. Aug 2020 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/nqaa072 ;PMID: 32320006

Full text available

Citations Cited by
7
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Material Type:
Article 		Add to My Research

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

The New England journal of medicine, 2010-07, Vol.363 (3), p.245-256 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0909809 ;PMID: 20647200 ;CODEN: NEJMAG

Full text available

Citations Cited by
8
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Material Type:
Article 		Add to My Research

Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome

The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.4048-4058 [Peer Reviewed Journal]

Copyright © 2015 by the Endocrine Society ;Copyright © 2015 by The Endocrine Society ;Copyright © 2015 by the Endocrine Society 2015 ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2015-2778 ;PMID: 26401593

Full text available

Citations Cited by
9
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Material Type:
Article 		Add to My Research

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes care, 2020-05, Vol.43 (5), p.1085-1093 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1745 ;PMID: 32139381

Full text available

Citations Cited by
10
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Material Type:
Article 		Add to My Research

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0234 ;PMID: 24144653 ;CODEN: DICAD2

Full text available

Citations Cited by
11
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
Material Type:
Article 		Add to My Research

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

The American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]

2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNAC

Full text available

Citations Cited by
12
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011-04, Vol.377 (9774), p.1341-1352 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 16-Apr 22, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60205-5 ;PMID: 21481449 ;CODEN: LANCAO

Full text available

Citations Cited by
13
The effects of oxytocin on eating behaviour and metabolism in humans
The effects of oxytocin on eating behaviour and metabolism in humans
Material Type:
Article 		Add to My Research

The effects of oxytocin on eating behaviour and metabolism in humans

Nature reviews. Endocrinology, 2017-12, Vol.13 (12), p.700-709 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2017 ;ISSN: 1759-5029 ;EISSN: 1759-5037 ;DOI: 10.1038/nrendo.2017.115 ;PMID: 28960210

Full text available

Citations Cited by
14
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Material Type:
Article 		Add to My Research

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics

Obesity (Silver Spring, Md.), 2023-01, Vol.31 (1), p.111-122 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of The Obesity Society. ;2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society. ;Copyright Blackwell Publishing Ltd. Jan 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23621 ;PMID: 36502289

Full text available

Citations Cited by
15
Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D–deficient overweight and obese children: a randomized clinical trial
Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D–deficient overweight and obese children: a randomized clinical trial
Material Type:
Article 		Add to My Research

Effect of vitamin D3 supplementation on vascular and metabolic health of vitamin D–deficient overweight and obese children: a randomized clinical trial

The American journal of clinical nutrition, 2020-04, Vol.111 (4), p.757-768 [Peer Reviewed Journal]

2020 American Society for Nutrition. ;Copyright © The Author(s) 2020. 2020 ;Copyright © The Author(s) 2020. ;Copyright American Society for Clinical Nutrition, Inc. Apr 2020 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/nqz340 ;PMID: 31950134

Full text available

Citations Cited by
16
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Material Type:
Article 		Add to My Research

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

The journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3067-3077 [Peer Reviewed Journal]

Copyright © 2011 by The Endocrine Society ;2015 INIST-CNRS ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-1256 ;PMID: 21795446 ;CODEN: JCEMAZ

Full text available

Citations Cited by
17
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2010-08, Vol.376 (9741), p.595-605 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 21-Aug 27, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60888-4 ;PMID: 20673995 ;CODEN: LANCAO

Full text available

Citations Cited by
18
A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
Material Type:
Article 		Add to My Research

A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults

The Journal of nutrition, 2013-03, Vol.143 (3), p.324-331 [Peer Reviewed Journal]

2013 American Society for Nutrition. ;2014 INIST-CNRS ;ISSN: 0022-3166 ;EISSN: 1541-6100 ;DOI: 10.3945/jn.112.166132 ;PMID: 23303873 ;CODEN: JONUAI

Full text available

Citations Cited by
19
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Material Type:
Article 		Add to My Research

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

The American journal of clinical nutrition, 2009-06, Vol.89 (6), p.1751-1759 [Peer Reviewed Journal]

2009 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Jun 1, 2009 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.2009.27465 ;PMID: 19386741 ;CODEN: AJCNAC

Full text available

Citations Cited by
20
Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program
Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program
Material Type:
Article 		Add to My Research

Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program

Diabetes (New York, N.Y.), 2016-05, Vol.65 (5), p.1424-1433 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association May 2016 ;2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db15-1063 ;PMID: 26861782 ;CODEN: DIAEAZ

Full text available

Citations Cited by

Results 1 - 20 of 237  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (223)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2009  (13)
  2. 2009 To 2011  (50)
  3. 2012 To 2014  (42)
  4. 2015 To 2018  (64)
  5. After 2018  (69)
  6. More options open sub menu

Language 

  1. English  (236)
  2. Japanese  (36)
  3. Spanish  (2)
  4. Portuguese  (1)
  5. Italian  (1)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait